For the quarter ended June 2026, Celanese (CE Quick QuoteCE - Free Report) reported revenue of $2.75 billion, up 8.7% over the same period last year. EPS came in at $2.45, compared to $1.44 in the year-ago quarter.

The reported revenue represents a surprise of +3.69% over the Zacks Consensus Estimate of $2.65 billion. With the consensus EPS estimate being $2.21, the EPS surprise was +10.86%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Celanese performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Volume - Acetyl Chain: 6% versus the three-analyst average estimate of 5.1%.
• Price - Engineered Materials: 6% compared to the -6.4% average estimate based on three analysts.
• Volume - Engineered Materials: 3% compared to the 4.8% average estimate based on three analysts.
• Price - Acetyl Chain: 22% compared to the 10.1% average estimate based on three analysts.
• Net Sales- Acetyl Chain: $1.33 billion versus the four-analyst average estimate of $1.22 billion. The reported number represents a year-over-year change of +19.2%.
• Net Sales- Intersegment Eliminations: $-23 million versus the four-analyst average estimate of $-27.5 million. The reported number represents a year-over-year change of -8%.
• Net Sales- Engineered Materials: $1.45 billion versus $1.42 billion estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +0.3% change.
• Operating EBITDA- Acetyl Chain: $385 million compared to the $375.27 million average estimate based on four analysts.
• Operating EBITDA- Other Activities: $-71 million compared to the $-66.5 million average estimate based on four analysts.
• Operating EBITDA- Engineered Materials: $335 million versus the four-analyst average estimate of $309.08 million.

View all Key Company Metrics for Celanese here>>>

Shares of Celanese have returned -7.9% over the past month versus the Zacks S&P 500 composite's +1.7% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.